chrX-84440548-C-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP3BS2
The NM_001177479.2(HDX):c.1289G>T(p.Cys430Phe) variant causes a missense change. The variant allele was found at a frequency of 0.0000288 in 1,181,118 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000099 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.000021 ( 0 hom. 6 hem. )
Consequence
HDX
NM_001177479.2 missense
NM_001177479.2 missense
Scores
1
10
6
Clinical Significance
Conservation
PhyloP100: 4.69
Genes affected
HDX (HGNC:26411): (highly divergent homeobox) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. Predicted to be part of chromatin. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.758
BS2
High Hemizygotes in GnomAdExome4 at 6 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HDX | NM_001177479.2 | c.1289G>T | p.Cys430Phe | missense_variant | 5/11 | ENST00000373177.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HDX | ENST00000373177.3 | c.1289G>T | p.Cys430Phe | missense_variant | 5/11 | 1 | NM_001177479.2 | P1 | |
HDX | ENST00000297977.9 | c.1289G>T | p.Cys430Phe | missense_variant | 4/10 | 1 | P1 | ||
HDX | ENST00000506585.6 | c.1115G>T | p.Cys372Phe | missense_variant | 4/10 | 2 | |||
HDX | ENST00000472135.2 | n.1143G>T | non_coding_transcript_exon_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000990 AC: 11AN: 111103Hom.: 0 Cov.: 23 AF XY: 0.0000299 AC XY: 1AN XY: 33445
GnomAD3 genomes
AF:
AC:
11
AN:
111103
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
33445
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000171 AC: 3AN: 175663Hom.: 0 AF XY: 0.0000164 AC XY: 1AN XY: 61111
GnomAD3 exomes
AF:
AC:
3
AN:
175663
Hom.:
AF XY:
AC XY:
1
AN XY:
61111
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000215 AC: 23AN: 1070015Hom.: 0 Cov.: 24 AF XY: 0.0000176 AC XY: 6AN XY: 340685
GnomAD4 exome
AF:
AC:
23
AN:
1070015
Hom.:
Cov.:
24
AF XY:
AC XY:
6
AN XY:
340685
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000990 AC: 11AN: 111103Hom.: 0 Cov.: 23 AF XY: 0.0000299 AC XY: 1AN XY: 33445
GnomAD4 genome
AF:
AC:
11
AN:
111103
Hom.:
Cov.:
23
AF XY:
AC XY:
1
AN XY:
33445
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 08, 2024 | The c.1289G>T (p.C430F) alteration is located in exon 5 (coding exon 3) of the HDX gene. This alteration results from a G to T substitution at nucleotide position 1289, causing the cysteine (C) at amino acid position 430 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;.;D
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;L
MutationTaster
Benign
D;D;D
PrimateAI
Benign
T
PROVEAN
Uncertain
D;.;.
REVEL
Uncertain
Sift
Uncertain
D;.;.
Sift4G
Uncertain
D;D;D
Polyphen
D;.;D
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at